Institutional Ownership Inhibikase Therapeutics, Inc. (IKT)
This table provides information about the institutional ownership of Inhibikase Therapeutics, Inc. (IKT). We have compiled data on the 2 institutions that hold shares in the stock, with a total of 1.03 Million shares, which have been reported (via 13F filing form) to have a value of $3.87 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
937,500
shares
|
$3 Million
1.18% of portfolio
|
Q2 2022
Reduced 12.91%
|
|
|
Zeke Capital Advisors, LLC
Berwyn, PA |
Feb 14, 2023 Q4 2022 |
93,800
shares
|
$300,160
0.0% of portfolio
|
Q2 2021
Added 398.94%
|